Sionna Therapeutics, Inc.
SION- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002036042
In the last 90 days, Sionna Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 146 institutions reported holding it in 13F filings for Q2 2026, worth $2.11B in total; Viking Global Investors is the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding Sionna Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 122 | 1 | 146 | +25 |
| Shares | 45.4M | 67 | 48.1M | +2.68M (+5.9%) |
| Value | $1.82B | $2.69K | $2.11B | +$294.2M (+16.2%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (34)
Institutions that held Sionna Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (9)
Institutions that held Sionna Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Polen Capital Management LLC | 26,775 | $1.07M |
| Susquehanna International Group, LLP | 7,310 | $293.1K |
| ExodusPoint Capital Management, LP | 7,190 | $288.2K |
| Hudson Bay Capital Management LP | 6,180 | $247.8K |
| Two Sigma Investments, LP | 5,500 | $220.5K |
| Cygnus Capital Advisors, LLC | 3,800 | $152.0K |
| Signaturefd, LLC | 24 | $962 |
| Root Financial Partners, LLC | 10 | $401 |
| MAI Capital Management | 2 | $81 |
Not filed for Q2 2026 yet (1)
Institutions that held Sionna Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 67 | $2.69K |